TrialTranslator uncovers the survival gap for high-risk patients and offers a path to better cancer research. Study: Evaluating generalizability of oncology trial results to real-world patients using ...
A scoping review shows machine learning models may help predict response to biologic and targeted synthetic DMARDs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback